Company Data
MiNK Therapeutics Inc.
Ticker
INKT
Current Price
$40.61 -36.71%
Market Cap
$161.9M
Price Target
Refer to Report
Volume
5.0M
52wk Range
$4.5601 - $76
Overview
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses.